Improved web-based calculators for predicting breast carcinoma outcomes

Breast Cancer Research and Treatment

Volumn 128, Issue 3, 2011, Pages 827-835

  Michaelson, James S ^a,b   Chen, L Leon ^a   Bush, Devon ^a   Fong, Allan ^a   Smith, Barbara ^a,b   Younger, Jerry ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; Calculator; Conditional survival; Epidemiology; Hazard function; Outcome; Survival

Indexed keywords

HORMONE RECEPTOR;

AGE; ARTICLE; BREAST CARCINOMA; CALCULATOR; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER MORTALITY; CANCER SURVIVAL; COMPUTER PROGRAM; HISTOPATHOLOGY; LIFE EXPECTANCY; LYMPH NODE; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; INTERNET; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; USER-COMPUTER INTERFACE; YOUNG ADULT;

EID: 79960844327     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1366-9     Document Type: Article

References (25)

1. J Lundin M Lundin J Isola, et al. 2003 A web-based system for individualised survival estimation in breast cancer BMJ 326 29 12511459 10.1136/bmj.326.7379.29
2. PM Ravdin LA Siminoff GJ Davis, et al. 2001 Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer J Clin Oncol 19 980 991 11181660 1:STN:280:DC%2BD3M3gsFalsg%3D%3D (Pubitemid 32176272)
3. IA Olivotto CD Bajdik PM Ravdin CH Speers AJ Coldman BD Norris GJ Davis SK Chia KA Gelmon 2005 Population-based validation of the prognostic model ADJUVANT! for early breast cancer J Clin Oncol 23 12 2716 2725 15837986 10.1200/JCO.2005.06.178 (Pubitemid 46179461)
4. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Lancet 365 9472 1687 1717 10.1016/S0140-6736(05)66544-0 (Pubitemid 40719106)
5. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) 2008 Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials Lancet 371 29 40 10.1016/S0140-6736(08)60069- 0
6. Michaelson JS, Technical Report #1-Mathematical Methods (March 9, 2009). http://cancer.lifemath.net/about/techreports/index.php
7. JS Michaelson, et al. 2009 How cancer at the primary site and in the nodes contributes to lethality Cancer 115 21 5095 5107 19670458 10.1002/cncr.24592
8. JS Michaelson, et al. 2009 Why cancer at the primary site and in the nodes contributes to lethality Cancer 115 21 5084 5094 19670457 10.1002/cncr.24542
9. JS Michaelson, et al. 2009 The impact of primary tumor size, nodal status, and other prognostic factors on the risk of cancer death CANCER 115 21 5071 5083 19658184 10.1002/cncr.24565
10. Michaelson JS, Technical Report #12-2nd Technical report for the paper: "CancerMath.net: Wed-based Calculators for Breast Carcinoma" (June 17, 2010). http://cancer.lifemath.net/about/techreports/index.php
11. A Mariotto EJ Feuer LC Harlan LM Wun KA Johnson J Abrams 2002 Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999 J Natl Cancer Inst 94 21 1626 1634 12419789 1:CAS:528:DC%2BD38XosFOgsb8%3D (Pubitemid 35378728)
12. Chen LL, and Michaelson JS (2009) Technical Report #9-Adjuvant Multi-agent Chemotherapy and Tamoxifen Usage Trends for Breast Cancer in the United States (March 27). http://cancer.lifemath.net/about/techreports/ technical-report-9.pdf
13. TG Karrison DJ Ferguson P Meier 1991 Dormancy of mammary carcinoma after mastectomy J Natl Cancer Inst 91 80 85
14. DA Berry C Cirrincione IC Henderson ML Citron DR Budman LJ Goldstein S Martino EA Perez HB Muss L Norton C Hudis EP Winer 2006 Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer JAMA. 295 14 1658 1667 16609087 10.1001/jama.295.14.1658 1:CAS:528:DC%2BD28XjsVeqs7k%3D
15. EM Ozanne D Braithwaite K Sepucha D Moore L Esserman J Belkora 2009 Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model J Clin Oncol 27 2 214 219 19047286 10.1200/JCO.2008.17.3914
16. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC Cancer Staging Manual, 7th edn. Springer, Berlin
17. JS Michaelson 2001 Using information on breast cancer growth, spread, and detectability to find the best ways to use screening to reduce breast cancer death J Woman's Imaging 3 54 57 10.1097/00130747-200105000-00002
18. KS Hughes LA Schnaper D Berry C Cirrincione B McCormick B Shank J Wheeler LA Champion TJ Smith BL Smith C Shapiro HB Muss E Winer C Hudis W Wood D Sugarbaker IC Henderson L Norton Leukemia Cancer B Group Radiation Therapy Oncology Group Eastern Cooperative Oncology Group 2004 Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer N Engl J Med 351 10 971 977 15342805 10.1056/NEJMoa040587 1:CAS:528:DC%2BD2cXnt12msrg%3D (Pubitemid 39166260)
19. AW Fyles DR McCready LA Manchul ME Trudeau P Merante M Pintilie LM Weir IA Olivotto 2004 Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer Engl J Med 351 10 963 970 10.1056/NEJMoa040595 1:CAS:528:DC%2BD2cXnt12nu7Y%3D (Pubitemid 39166259)
20. J Michaelson E Halpern D Kopans 1999 A computer simulation method for estimating the optimal intervals for breast cancer screening Radiology 212 551 560 10429717 1:STN:280:DyaK1MzlvVenug%3D%3D (Pubitemid 29356580)
21. JS Michaelson M Silverstein J Wyatt G Weber R Moore DB Kopans K Hughes 2002 Predicting the survival of patients with breast carcinoma using tumor size CANCER 95 713 723 12209713 10.1002/cncr.10742 (Pubitemid 34839661)
22. K Hughes K Tanabe B Smith J Michaelson 2004 Mammographic screening: patterns of use and estimated impact on breast carcinoma survival Cancer 101 495 507 15274062 10.1002/cncr.20481 (Pubitemid 39100430)
23. Michaelson J (2007) Mammographic screening: impact on survival. In: Hayat MA (ed) Cancer imaging. Elsevier, Amsterdam
24. National Vital Statistics Reports Vol. 54 No. 14, April 19, 2006, United States Life Tables (2003)
25. S Mook M Schmidt EJ Rutgers, et al. 2009 Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study Lancet Oncol 10 1070 1076 19801202 10.1016/S1470-2045(09)70254-2